| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.27e-04 | 50 | 39 | 3 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.51e-04 | 53 | 39 | 3 | GO:0016859 | |
| GeneOntologyMolecularFunction | cyclosporin A binding | 9.98e-04 | 24 | 39 | 2 | GO:0016018 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | RBMY1D RBMY1B RBMY1E CCNL2 TRA2A TRA2B CLK2 CLK3 RBMY1A1 RBMY1C RBMY1F CCNL1 | 1.63e-15 | 207 | 38 | 12 | GO:0043484 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 1.02e-14 | 44 | 38 | 8 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 2.58e-14 | 49 | 38 | 8 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 2.17e-13 | 63 | 38 | 8 | GO:0033120 | |
| GeneOntologyBiologicalProcess | RNA splicing | RBMY1D RBMY1B RBMY1E CCNL2 TRA2A PPIG TRA2B CLK2 CLK3 RBMY1A1 RBMY1C RBMY1F CCNL1 | 2.80e-12 | 502 | 38 | 13 | GO:0008380 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | RBMY1D RBMY1B RBMY1E TRA2A FIP1L1 TRA2B RBMY1A1 RBMY1C RBMY1F | 9.73e-12 | 158 | 38 | 9 | GO:0050684 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 7.85e-11 | 129 | 38 | 8 | GO:0048024 | |
| GeneOntologyBiologicalProcess | RNA processing | RBMY1D RBMY1B RBMY1E CCNL2 TRA2A FIP1L1 PPIG TRA2B CPSF6 CLK2 CLK3 RBMY1A1 RBMY1C RBMY1F CCNL1 RBM26 | 2.71e-09 | 1500 | 38 | 16 | GO:0006396 |
| GeneOntologyBiologicalProcess | mRNA processing | RBMY1D RBMY1B RBMY1E TRA2A FIP1L1 TRA2B CPSF6 RBMY1A1 RBMY1C RBMY1F RBM26 | 2.80e-09 | 551 | 38 | 11 | GO:0006397 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.96e-08 | 259 | 38 | 8 | GO:1903313 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | RBMY1D RBMY1B RBMY1E TRA2A FIP1L1 TRA2B RBMY1A1 RBMY1C RBMY1F | 8.41e-08 | 443 | 38 | 9 | GO:1903311 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.36e-07 | 358 | 38 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.36e-07 | 358 | 38 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.57e-07 | 362 | 38 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | RBMY1D RBMY1B RBMY1E TRA2A FIP1L1 TRA2B CPSF6 RBMY1A1 RBMY1C RBMY1F RBM26 | 5.04e-07 | 917 | 38 | 11 | GO:0016071 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.65e-05 | 38 | 38 | 3 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.34e-04 | 54 | 38 | 3 | GO:0018208 | |
| GeneOntologyBiologicalProcess | male gonad development | 2.70e-04 | 171 | 38 | 4 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 2.76e-04 | 172 | 38 | 4 | GO:0046546 | |
| GeneOntologyBiologicalProcess | regulation of RNA export from nucleus | 4.42e-04 | 17 | 38 | 2 | GO:0046831 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 4.62e-04 | 197 | 38 | 4 | GO:0002244 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 4.80e-04 | 199 | 38 | 4 | GO:0046661 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 6.15e-04 | 20 | 38 | 2 | GO:0032239 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | RBMY1D RBMY1B RBMY1E TRA2A SETD2 TRA2B RBMY1A1 RBMY1C RBMY1F | 1.01e-03 | 1446 | 38 | 9 | GO:0010628 |
| GeneOntologyBiologicalProcess | gonad development | 1.99e-03 | 292 | 38 | 4 | GO:0008406 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 2.11e-03 | 297 | 38 | 4 | GO:0045137 | |
| GeneOntologyCellularComponent | spliceosomal complex | 5.14e-09 | 215 | 39 | 8 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear speck | 1.08e-06 | 431 | 39 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RBMY1D RBMY1B RBMY1E TRA2A FIP1L1 TRA2B MGA CPSF6 RBMY1A1 RBMY1C RBMY1F CCNL1 | 4.69e-06 | 1377 | 39 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.97e-05 | 86 | 39 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | RBMY1D RBMY1B RBMY1E TRA2A SRP68 TRA2B CPSF6 RBMY1A1 RBMY1C RBMY1F | 4.94e-05 | 1194 | 39 | 10 | GO:1990904 |
| GeneOntologyCellularComponent | germ cell nucleus | 5.75e-05 | 113 | 39 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | nuclear body | 2.19e-04 | 903 | 39 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 1.07e-03 | 26 | 39 | 2 | GO:0005847 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.52e-03 | 31 | 39 | 2 | GO:0005849 | |
| Domain | RRM_1 | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1A1 RBMY1F RBM26 | 2.32e-13 | 208 | 38 | 11 | PF00076 |
| Domain | RRM | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1A1 RBMY1F RBM26 | 3.69e-13 | 217 | 38 | 11 | SM00360 |
| Domain | RRM_dom | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1A1 RBMY1F RBM26 | 6.05e-13 | 227 | 38 | 11 | IPR000504 |
| Domain | RRM | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1A1 RBMY1F RBM26 | 6.98e-13 | 230 | 38 | 11 | PS50102 |
| Domain | RBM1CTR | 1.48e-12 | 8 | 38 | 5 | PF08081 | |
| Domain | RBM1CTR | 1.48e-12 | 8 | 38 | 5 | IPR012604 | |
| Domain | Nucleotide-bd_a/b_plait | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1A1 RBMY1F RBM26 | 2.44e-12 | 258 | 38 | 11 | IPR012677 |
| Domain | - | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1F RBM26 | 4.13e-11 | 244 | 38 | 10 | 3.30.70.330 |
| Domain | Cyclophilin-type_PPIase | 1.01e-05 | 21 | 38 | 3 | IPR024936 | |
| Domain | Pro_isomerase | 1.17e-05 | 22 | 38 | 3 | PF00160 | |
| Domain | - | 1.17e-05 | 22 | 38 | 3 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.17e-05 | 22 | 38 | 3 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 1.17e-05 | 22 | 38 | 3 | IPR029000 | |
| Domain | CSA_PPIASE_1 | 1.17e-05 | 22 | 38 | 3 | PS00170 | |
| Domain | CSA_PPIASE_2 | 1.17e-05 | 22 | 38 | 3 | PS50072 | |
| Domain | Cyclin_L/T | 1.12e-04 | 8 | 38 | 2 | IPR015429 | |
| Domain | Cyclin_C-dom | 5.38e-04 | 17 | 38 | 2 | IPR004367 | |
| Domain | Cyclin_C | 5.38e-04 | 17 | 38 | 2 | PF02984 | |
| Domain | Cyclin_C | 5.38e-04 | 17 | 38 | 2 | SM01332 | |
| Domain | Cyclophilin-type_PPIase_CS | 6.74e-04 | 19 | 38 | 2 | IPR020892 | |
| Domain | CYCLINS | 1.47e-03 | 28 | 38 | 2 | PS00292 | |
| Domain | Cyclin_N | 2.05e-03 | 33 | 38 | 2 | IPR006671 | |
| Domain | Cyclin_N | 2.05e-03 | 33 | 38 | 2 | PF00134 | |
| Domain | CYCLIN | 2.71e-03 | 38 | 38 | 2 | SM00385 | |
| Domain | - | 2.99e-03 | 40 | 38 | 2 | 4.10.1000.10 | |
| Domain | - | 2.99e-03 | 40 | 38 | 2 | 1.10.472.10 | |
| Domain | Cyclin-like | 3.45e-03 | 43 | 38 | 2 | IPR013763 | |
| Domain | ZnF_C3H1 | 4.29e-03 | 48 | 38 | 2 | SM00356 | |
| Domain | zf-CCCH | 4.46e-03 | 49 | 38 | 2 | PF00642 | |
| Domain | Znf_CCCH | 6.20e-03 | 58 | 38 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 6.20e-03 | 58 | 38 | 2 | PS50103 | |
| Pathway | WP_MRNA_PROCESSING | RBMY1D PPIL4 RBMY1B RBMY1E SRP68 TRA2B CLK2 CLK3 RBMY1A1 RBM26 TTC14 | 1.00e-09 | 451 | 30 | 11 | MM15946 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.97e-04 | 283 | 30 | 5 | M13087 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 8.12e-04 | 20 | 30 | 2 | MM15469 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 8.12e-04 | 20 | 30 | 2 | M497 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.08e-03 | 23 | 30 | 2 | M41817 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.27e-03 | 25 | 30 | 2 | MM15608 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.72e-03 | 29 | 30 | 2 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.72e-03 | 29 | 30 | 2 | MM15444 | |
| Pathway | WP_MRNA_PROCESSING | 2.37e-03 | 126 | 30 | 3 | M39406 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 2.49e-03 | 35 | 30 | 2 | M41738 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.67e-03 | 277 | 30 | 4 | MM15414 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 2.78e-03 | 37 | 30 | 2 | MM15683 | |
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 8269511 | ||
| Pubmed | 1.22e-15 | 12 | 39 | 6 | 9598316 | ||
| Pubmed | 8.14e-15 | 6 | 39 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 2.85e-14 | 7 | 39 | 5 | 8875892 | |
| Pubmed | 1.74e-12 | 13 | 39 | 5 | 10749975 | ||
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 20016065 | ||
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 6.74e-12 | 5 | 39 | 4 | 8817321 | |
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 6.74e-12 | 5 | 39 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 6.74e-12 | 5 | 39 | 4 | 19737860 | |
| Pubmed | 8.07e-12 | 251 | 39 | 9 | 31076518 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 2.02e-11 | 6 | 39 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 2.02e-11 | 6 | 39 | 4 | 12356914 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 18239052 | ||
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 15051956 | ||
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 9499427 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 4.71e-11 | 7 | 39 | 4 | 10377282 | |
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 7479793 | ||
| Pubmed | 1.44e-10 | 347 | 39 | 9 | 16033648 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CACNG2 TJP2 TRA2A FIP1L1 PPIG SETD2 TRA2B RBBP6 CPSF6 CLK2 CLK3 | 1.89e-10 | 695 | 39 | 11 | 23602568 |
| Pubmed | 2.82e-10 | 10 | 39 | 4 | 10601091 | ||
| Pubmed | 2.82e-10 | 10 | 39 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 6.64e-10 | 12 | 39 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 9.58e-10 | 13 | 39 | 4 | 23816659 | |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 1.34e-09 | 14 | 39 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 1.83e-09 | 15 | 39 | 4 | 14762062 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 3.18e-09 | 17 | 39 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 4.08e-09 | 18 | 39 | 4 | 12023983 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PPIL4 TOM1L2 TJP2 DNAAF3 FIP1L1 SRP68 SETD2 PJA1 CPSF6 RBM26 SEC16A | 1.24e-08 | 1038 | 39 | 11 | 26673895 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.48e-08 | 807 | 39 | 10 | 22681889 | |
| Pubmed | 1.98e-08 | 26 | 39 | 4 | 35920200 | ||
| Pubmed | 6.48e-08 | 188 | 39 | 6 | 29721183 | ||
| Pubmed | 7.44e-08 | 713 | 39 | 9 | 29802200 | ||
| Pubmed | 8.37e-08 | 723 | 39 | 9 | 34133714 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NARS1 TJP2 TRA2A SRP68 PPIG NKTR TRA2B RBBP6 CPSF6 CLK2 SEC16A | 1.40e-07 | 1318 | 39 | 11 | 30463901 |
| Pubmed | PPIL4 NARS1 TJP2 TRA2A FIP1L1 SRP68 PPIG NKTR CPSF6 RBM26 SEC16A | 2.08e-07 | 1371 | 39 | 11 | 36244648 | |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 2.14e-07 | 11 | 39 | 3 | 14729963 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.28e-07 | 1082 | 39 | 10 | 38697112 | |
| Pubmed | 3.90e-07 | 255 | 39 | 6 | 15324660 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 4.42e-07 | 55 | 39 | 4 | 19468303 | |
| Pubmed | 5.45e-07 | 653 | 39 | 8 | 33742100 | ||
| Pubmed | 5.88e-07 | 59 | 39 | 4 | 11279525 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 1.23e-06 | 2 | 39 | 2 | 32473614 | |
| Pubmed | Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. | 1.23e-06 | 2 | 39 | 2 | 9546399 | |
| Pubmed | Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression. | 1.23e-06 | 2 | 39 | 2 | 25970345 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 9637771 | ||
| Pubmed | 1.29e-06 | 733 | 39 | 8 | 34672954 | ||
| Pubmed | 1.31e-06 | 503 | 39 | 7 | 16964243 | ||
| Pubmed | 1.42e-06 | 1014 | 39 | 9 | 32416067 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.85e-06 | 182 | 39 | 5 | 32239614 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.94e-06 | 774 | 39 | 8 | 15302935 | |
| Pubmed | 2.33e-06 | 549 | 39 | 7 | 38280479 | ||
| Pubmed | 2.45e-06 | 1084 | 39 | 9 | 11544199 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 2.58e-06 | 353 | 39 | 6 | 27545878 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 2.73e-06 | 197 | 39 | 5 | 22365833 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.79e-06 | 358 | 39 | 6 | 32460013 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.93e-06 | 361 | 39 | 6 | 26167880 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18216018 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15937220 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22194695 | ||
| Pubmed | CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. | 3.67e-06 | 3 | 39 | 2 | 17261272 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12165565 | ||
| Pubmed | Characterization of cyclin L1 as an immobile component of the splicing factor compartment. | 3.67e-06 | 3 | 39 | 2 | 17494991 | |
| Pubmed | Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA. | 3.67e-06 | 3 | 39 | 2 | 23255807 | |
| Pubmed | 3.99e-06 | 95 | 39 | 4 | 24029230 | ||
| Pubmed | 5.72e-06 | 104 | 39 | 4 | 31365120 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 7.02e-06 | 922 | 39 | 8 | 27609421 | |
| Pubmed | The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. | 7.28e-06 | 241 | 39 | 5 | 12815422 | |
| Pubmed | Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. | 7.34e-06 | 4 | 39 | 2 | 2217177 | |
| Pubmed | Characterization and comparison of four serine- and arginine-rich (SR) protein kinases. | 7.34e-06 | 4 | 39 | 2 | 9307018 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 24436071 | ||
| Pubmed | Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. | 7.34e-06 | 4 | 39 | 2 | 14765198 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 7990150 | ||
| Pubmed | Chromosomal mapping of three human LAMMER protein-kinase-encoding genes. | 7.34e-06 | 4 | 39 | 2 | 9856501 | |
| Pubmed | Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. | 7.34e-06 | 4 | 39 | 2 | 29276085 | |
| Pubmed | 7.63e-06 | 1247 | 39 | 9 | 27684187 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 8.14e-06 | 1257 | 39 | 9 | 36526897 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 9.00e-06 | 954 | 39 | 8 | 36373674 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 9.28e-06 | 678 | 39 | 7 | 30209976 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 9.39e-06 | 254 | 39 | 5 | 28431233 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.03e-05 | 259 | 39 | 5 | 30404004 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.15e-05 | 701 | 39 | 7 | 30196744 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 11683997 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 17516030 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 28785060 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 19168442 | ||
| Pubmed | 1.26e-05 | 1327 | 39 | 9 | 32694731 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.30e-05 | 714 | 39 | 7 | 28302793 | |
| Pubmed | 1.51e-05 | 731 | 39 | 7 | 29298432 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.58e-05 | 283 | 39 | 5 | 30585729 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 19282290 | ||
| Pubmed | 1.84e-05 | 754 | 39 | 7 | 35906200 | ||
| Pubmed | 2.23e-05 | 777 | 39 | 7 | 35844135 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 15169763 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 3.30e-05 | 330 | 39 | 5 | 33301849 | |
| Pubmed | SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. | 3.42e-05 | 8 | 39 | 2 | 9671816 | |
| Pubmed | RBBP6 activates the pre-mRNA 3' end processing machinery in humans. | 3.42e-05 | 8 | 39 | 2 | 35177536 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.85e-05 | 341 | 39 | 5 | 32971831 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 4.27e-05 | 60 | 39 | 3 | 29055695 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 14623875 | ||
| Interaction | RNPS1 interactions | CCNL2 TRA2A FIP1L1 PPIG SETD2 NKTR TRA2B RBBP6 CPSF6 CLK2 CLK3 RBMY1F CCNL1 | 6.72e-13 | 425 | 39 | 13 | int:RNPS1 |
| Interaction | CLK2 interactions | 1.02e-10 | 195 | 39 | 9 | int:CLK2 | |
| Interaction | JMJD6 interactions | 1.59e-10 | 205 | 39 | 9 | int:JMJD6 | |
| Interaction | SRPK2 interactions | CACNG2 TJP2 TRA2A FIP1L1 PPIG SETD2 NKTR TRA2B RBBP6 CPSF6 CLK2 CLK3 RBM26 | 4.54e-10 | 717 | 39 | 13 | int:SRPK2 |
| Interaction | DHX40 interactions | 8.91e-10 | 249 | 39 | 9 | int:DHX40 | |
| Interaction | CPSF6 interactions | PPIL4 TRA2A FIP1L1 PPIG SETD2 NKTR TRA2B RBBP6 CPSF6 CLK2 RBM26 | 2.99e-09 | 526 | 39 | 11 | int:CPSF6 |
| Interaction | SAP18 interactions | 5.27e-09 | 305 | 39 | 9 | int:SAP18 | |
| Interaction | RBMY1F interactions | 7.50e-09 | 36 | 39 | 5 | int:RBMY1F | |
| Interaction | CLK3 interactions | 8.17e-09 | 220 | 39 | 8 | int:CLK3 | |
| Interaction | SRRM2 interactions | 1.28e-08 | 462 | 39 | 10 | int:SRRM2 | |
| Interaction | LUC7L interactions | 1.72e-08 | 242 | 39 | 8 | int:LUC7L | |
| Interaction | DDX23 interactions | 1.83e-08 | 480 | 39 | 10 | int:DDX23 | |
| Interaction | SNRPA interactions | TRA2A FIP1L1 PPIG SETD2 NKTR TRA2B RBBP6 CLK2 RBMY1A1 RBMY1F | 1.90e-08 | 482 | 39 | 10 | int:SNRPA |
| Interaction | NKAPD1 interactions | 2.26e-08 | 161 | 39 | 7 | int:NKAPD1 | |
| Interaction | RBM39 interactions | PPIL4 NARS1 TJP2 TRA2A PPIG SETD2 NKTR TRA2B CPSF6 CLK2 CLK3 SEC16A TTC14 | 4.05e-08 | 1042 | 39 | 13 | int:RBM39 |
| Interaction | DHX8 interactions | 7.35e-08 | 292 | 39 | 8 | int:DHX8 | |
| Interaction | SRSF7 interactions | 9.17e-08 | 425 | 39 | 9 | int:SRSF7 | |
| Interaction | SNRPC interactions | 1.23e-07 | 440 | 39 | 9 | int:SNRPC | |
| Interaction | RAD18 interactions | 1.70e-07 | 457 | 39 | 9 | int:RAD18 | |
| Interaction | CLK1 interactions | 1.86e-07 | 219 | 39 | 7 | int:CLK1 | |
| Interaction | RSRP1 interactions | 2.03e-07 | 27 | 39 | 4 | int:RSRP1 | |
| Interaction | RBMY1J interactions | 2.75e-07 | 29 | 39 | 4 | int:RBMY1J | |
| Interaction | PABPC5 interactions | 2.97e-07 | 142 | 39 | 6 | int:PABPC5 | |
| Interaction | SRSF6 interactions | 3.81e-07 | 503 | 39 | 9 | int:SRSF6 | |
| Interaction | RBMY1A1 interactions | 4.14e-07 | 32 | 39 | 4 | int:RBMY1A1 | |
| Interaction | TRA2B interactions | 6.05e-07 | 385 | 39 | 8 | int:TRA2B | |
| Interaction | YTHDC1 interactions | 1.10e-06 | 417 | 39 | 8 | int:YTHDC1 | |
| Interaction | SNIP1 interactions | 1.10e-06 | 417 | 39 | 8 | int:SNIP1 | |
| Interaction | SRSF8 interactions | 1.24e-06 | 98 | 39 | 5 | int:SRSF8 | |
| Interaction | MIR19A interactions | 1.37e-06 | 100 | 39 | 5 | int:MIR19A | |
| Interaction | SRSF4 interactions | 1.54e-06 | 300 | 39 | 7 | int:SRSF4 | |
| Interaction | PNN interactions | 1.61e-06 | 302 | 39 | 7 | int:PNN | |
| Interaction | MIR19B1 interactions | 1.66e-06 | 104 | 39 | 5 | int:MIR19B1 | |
| Interaction | GSPT2 interactions | 1.91e-06 | 107 | 39 | 5 | int:GSPT2 | |
| Interaction | TRA2A interactions | 2.90e-06 | 330 | 39 | 7 | int:TRA2A | |
| Interaction | ZC3H11A interactions | 3.34e-06 | 215 | 39 | 6 | int:ZC3H11A | |
| Interaction | RBBP6 interactions | 3.43e-06 | 216 | 39 | 6 | int:RBBP6 | |
| Interaction | RNF151 interactions | 3.81e-06 | 123 | 39 | 5 | int:RNF151 | |
| Interaction | CCNT1 interactions | 4.34e-06 | 225 | 39 | 6 | int:CCNT1 | |
| Interaction | PPIG interactions | 4.45e-06 | 127 | 39 | 5 | int:PPIG | |
| Interaction | ZC3H18 interactions | 4.66e-06 | 877 | 39 | 10 | int:ZC3H18 | |
| Interaction | TNPO3 interactions | 5.85e-06 | 237 | 39 | 6 | int:TNPO3 | |
| Interaction | LARP4B interactions | 6.29e-06 | 240 | 39 | 6 | int:LARP4B | |
| Interaction | CSTF3 interactions | 6.92e-06 | 139 | 39 | 5 | int:CSTF3 | |
| Interaction | WDR33 interactions | 8.51e-06 | 145 | 39 | 5 | int:WDR33 | |
| Interaction | CPSF1 interactions | 8.90e-06 | 255 | 39 | 6 | int:CPSF1 | |
| Interaction | PCDHB14 interactions | 1.01e-05 | 22 | 39 | 3 | int:PCDHB14 | |
| Interaction | SNRNP70 interactions | 1.28e-05 | 984 | 39 | 10 | int:SNRNP70 | |
| Interaction | PRPF38A interactions | 1.41e-05 | 161 | 39 | 5 | int:PRPF38A | |
| Interaction | MIR92A1 interactions | 1.54e-05 | 78 | 39 | 4 | int:MIR92A1 | |
| Interaction | HNRNPUL2 interactions | 1.88e-05 | 291 | 39 | 6 | int:HNRNPUL2 | |
| Interaction | RBMY1E interactions | 2.18e-05 | 4 | 39 | 2 | int:RBMY1E | |
| Interaction | MECP2 interactions | PPIL4 TRA2A FIP1L1 SRP68 PPIG SETD2 NKTR TRA2B RBBP6 CPSF6 CLK3 | 2.19e-05 | 1287 | 39 | 11 | int:MECP2 |
| Interaction | RBMX interactions | 2.56e-05 | 461 | 39 | 7 | int:RBMX | |
| Interaction | CPSF4 interactions | 3.22e-05 | 94 | 39 | 4 | int:CPSF4 | |
| Interaction | YAP1 interactions | 3.22e-05 | 1095 | 39 | 10 | int:YAP1 | |
| Interaction | KDF1 interactions | 3.30e-05 | 192 | 39 | 5 | int:KDF1 | |
| Interaction | PRP4K interactions | 3.75e-05 | 329 | 39 | 6 | int:PRP4K | |
| Interaction | MIR128-2 interactions | 3.95e-05 | 99 | 39 | 4 | int:MIR128-2 | |
| Interaction | BRD3 interactions | 3.97e-05 | 494 | 39 | 7 | int:BRD3 | |
| Interaction | MIRLET7B interactions | 4.27e-05 | 101 | 39 | 4 | int:MIRLET7B | |
| Interaction | SRSF11 interactions | 4.30e-05 | 203 | 39 | 5 | int:SRSF11 | |
| Interaction | SRRT interactions | 4.50e-05 | 340 | 39 | 6 | int:SRRT | |
| Interaction | MIR34A interactions | 4.79e-05 | 104 | 39 | 4 | int:MIR34A | |
| Interaction | NR2C2 interactions | NARS1 TJP2 TRA2A SRP68 PPIG NKTR TRA2B RBBP6 CPSF6 CLK2 SEC16A | 4.87e-05 | 1403 | 39 | 11 | int:NR2C2 |
| Interaction | LUC7L2 interactions | 5.54e-05 | 353 | 39 | 6 | int:LUC7L2 | |
| Interaction | SRSF3 interactions | 5.63e-05 | 522 | 39 | 7 | int:SRSF3 | |
| Interaction | PIP4K2A interactions | 5.78e-05 | 216 | 39 | 5 | int:PIP4K2A | |
| Interaction | PURG interactions | 6.72e-05 | 223 | 39 | 5 | int:PURG | |
| Interaction | FIP1L1 interactions | 7.01e-05 | 225 | 39 | 5 | int:FIP1L1 | |
| Interaction | ZCCHC10 interactions | 8.78e-05 | 236 | 39 | 5 | int:ZCCHC10 | |
| Interaction | SMC5 interactions | 9.69e-05 | 1000 | 39 | 9 | int:SMC5 | |
| Interaction | YWHAG interactions | 9.73e-05 | 1248 | 39 | 10 | int:YWHAG | |
| Interaction | SRSF1 interactions | 9.77e-05 | 570 | 39 | 7 | int:SRSF1 | |
| Interaction | ANAPC15 interactions | 1.07e-04 | 128 | 39 | 4 | int:ANAPC15 | |
| Interaction | RNF31 interactions | 1.15e-04 | 403 | 39 | 6 | int:RNF31 | |
| Interaction | NKAP interactions | 1.21e-04 | 132 | 39 | 4 | int:NKAP | |
| Interaction | CSNK1D interactions | 1.24e-04 | 254 | 39 | 5 | int:CSNK1D | |
| Interaction | LLGL2 interactions | 1.25e-04 | 133 | 39 | 4 | int:LLGL2 | |
| Interaction | ATXN1 interactions | 1.30e-04 | 1039 | 39 | 9 | int:ATXN1 | |
| Interaction | BIVM-ERCC5 interactions | 1.63e-04 | 10 | 39 | 2 | int:BIVM-ERCC5 | |
| Interaction | SRSF10 interactions | 1.68e-04 | 271 | 39 | 5 | int:SRSF10 | |
| Interaction | NUP43 interactions | 1.73e-04 | 625 | 39 | 7 | int:NUP43 | |
| Interaction | ZBTB38 interactions | 1.74e-04 | 145 | 39 | 4 | int:ZBTB38 | |
| Interaction | PPHLN1 interactions | 1.79e-04 | 146 | 39 | 4 | int:PPHLN1 | |
| Interaction | LATS1 interactions | 1.85e-04 | 440 | 39 | 6 | int:LATS1 | |
| Interaction | HNRNPC interactions | 1.89e-04 | 634 | 39 | 7 | int:HNRNPC | |
| Interaction | THRAP3 interactions | 1.92e-04 | 443 | 39 | 6 | int:THRAP3 | |
| Interaction | PRPF40A interactions | 2.00e-04 | 446 | 39 | 6 | int:PRPF40A | |
| Interaction | MEPCE interactions | 2.00e-04 | 859 | 39 | 8 | int:MEPCE | |
| Interaction | U2AF2 interactions | 2.22e-04 | 651 | 39 | 7 | int:U2AF2 | |
| Interaction | TAS2R42 interactions | 2.38e-04 | 12 | 39 | 2 | int:TAS2R42 | |
| Interaction | MFAP1 interactions | 2.49e-04 | 295 | 39 | 5 | int:MFAP1 | |
| Interaction | ZNF317 interactions | 2.57e-04 | 64 | 39 | 3 | int:ZNF317 | |
| Interaction | HNRNPCL1 interactions | 2.60e-04 | 161 | 39 | 4 | int:HNRNPCL1 | |
| Interaction | RC3H1 interactions | 2.82e-04 | 677 | 39 | 7 | int:RC3H1 | |
| Interaction | SRPK1 interactions | 2.86e-04 | 477 | 39 | 6 | int:SRPK1 | |
| Interaction | CHMP4C interactions | 3.08e-04 | 687 | 39 | 7 | int:CHMP4C | |
| Interaction | HMGB1 interactions | 3.17e-04 | 486 | 39 | 6 | int:HMGB1 | |
| Interaction | ATXN2 interactions | 3.22e-04 | 312 | 39 | 5 | int:ATXN2 | |
| Cytoband | Yq11.223 | 1.67e-08 | 93 | 39 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 6.58e-06 | 311 | 39 | 5 | chrYq11 | |
| Cytoband | 17q25.1 | 2.18e-03 | 81 | 39 | 2 | 17q25.1 | |
| GeneFamily | RNA binding motif containing | RBMY1D PPIL4 RBMY1B RBMY1E TRA2A TRA2B PPRC1 CPSF6 RBMY1A1 RBMY1C RBMY1F RBM26 | 3.76e-16 | 213 | 30 | 12 | 725 |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 3.92e-06 | 19 | 30 | 3 | 909 | |
| GeneFamily | CDC like kinases | 1.59e-05 | 4 | 30 | 2 | 480 | |
| GeneFamily | Cyclins | 9.79e-04 | 28 | 30 | 2 | 473 | |
| GeneFamily | Zinc fingers CCCH-type | 1.53e-03 | 35 | 30 | 2 | 73 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.49e-07 | 33 | 38 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 5.36e-07 | 45 | 38 | 4 | MM763 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 4.07e-06 | 166 | 38 | 5 | M8129 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 3.42e-05 | 432 | 38 | 6 | M41149 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP | 8.00e-05 | 158 | 38 | 4 | M8888 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 1.44e-04 | 184 | 38 | 4 | M19988 | |
| Coexpression | RICKMAN_METASTASIS_UP | 1.44e-04 | 350 | 38 | 5 | M9752 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP | 1.91e-04 | 198 | 38 | 4 | M9921 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 1.91e-04 | 198 | 38 | 4 | M7605 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 1.91e-04 | 198 | 38 | 4 | M5293 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN | 1.94e-04 | 199 | 38 | 4 | M3716 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN | 1.98e-04 | 200 | 38 | 4 | M6411 | |
| Coexpression | GSE17721_4_VS_24H_CPG_BMDC_UP | 1.98e-04 | 200 | 38 | 4 | M4130 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | 2.08e-04 | 600 | 38 | 6 | MM1025 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.16e-07 | 197 | 36 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.56e-07 | 200 | 36 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-05 | 191 | 36 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 1.77e-05 | 194 | 36 | 4 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.84e-05 | 196 | 36 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.84e-05 | 196 | 36 | 4 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.92e-05 | 198 | 36 | 4 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-05 | 200 | 36 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-05 | 10 | 36 | 2 | ac77ca7ae0d6ba7b6770d966e3e250ca80c51f68 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.25e-04 | 147 | 36 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.54e-04 | 153 | 36 | 3 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.54e-04 | 153 | 36 | 3 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 3.51e-04 | 171 | 36 | 3 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 3.95e-04 | 178 | 36 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.15e-04 | 181 | 36 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-04 | 182 | 36 | 3 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.28e-04 | 183 | 36 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.35e-04 | 184 | 36 | 3 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.42e-04 | 185 | 36 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 4.42e-04 | 185 | 36 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.56e-04 | 187 | 36 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.70e-04 | 189 | 36 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.85e-04 | 191 | 36 | 3 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.92e-04 | 192 | 36 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 5.00e-04 | 193 | 36 | 3 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.00e-04 | 193 | 36 | 3 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 5.08e-04 | 194 | 36 | 3 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.15e-04 | 195 | 36 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 195 | 36 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 195 | 36 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.23e-04 | 196 | 36 | 3 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 5.23e-04 | 196 | 36 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.31e-04 | 197 | 36 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 5.31e-04 | 197 | 36 | 3 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-04 | 197 | 36 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 5.39e-04 | 198 | 36 | 3 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-04 | 198 | 36 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 5.39e-04 | 198 | 36 | 3 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-04 | 198 | 36 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 5.39e-04 | 198 | 36 | 3 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.39e-04 | 198 | 36 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 5.46e-04 | 199 | 36 | 3 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.46e-04 | 199 | 36 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.46e-04 | 199 | 36 | 3 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 5.55e-04 | 200 | 36 | 3 | c2df917900872453ea17a39928e39d071a6d3339 | |
| Computational | Neighborhood of HDAC1 | 6.59e-05 | 110 | 22 | 4 | GNF2_HDAC1 | |
| Drug | hydantoin-5-propionic acid | 3.87e-08 | 21 | 38 | 4 | CID000000782 | |
| Drug | AZFd | 5.71e-08 | 23 | 38 | 4 | CID000196489 | |
| Drug | Vistar | 3.74e-07 | 36 | 38 | 4 | CID000040896 | |
| Drug | bipy | 5.68e-07 | 97 | 38 | 5 | CID000001474 | |
| Drug | 2-chlorodideoxyadenosine | 7.77e-07 | 43 | 38 | 4 | CID000072194 | |
| Drug | 2-oyl | 8.43e-07 | 105 | 38 | 5 | CID000657137 | |
| Drug | PKI166 | 1.22e-06 | 48 | 38 | 4 | CID006918403 | |
| Drug | HgCl | 1.32e-06 | 49 | 38 | 4 | CID000024182 | |
| Drug | azafagomine | 2.44e-06 | 57 | 38 | 4 | CID011957435 | |
| Drug | thioglycolate | 4.69e-06 | 67 | 38 | 4 | CID000001133 | |
| Drug | SU6668 | 5.59e-06 | 70 | 38 | 4 | CID000206042 | |
| Drug | p11-13 | 7.36e-06 | 75 | 38 | 4 | CID000015759 | |
| Drug | carbonyl sulfide | 4.13e-05 | 116 | 38 | 4 | CID000010039 | |
| Drug | Meala-csa | 1.21e-04 | 10 | 38 | 2 | CID006436248 | |
| Drug | oligoadenylate | 1.34e-04 | 157 | 38 | 4 | CID000107918 | |
| Drug | Ticalopride | 1.48e-04 | 11 | 38 | 2 | CID000216236 | |
| Drug | 1-methylurate | 1.48e-04 | 11 | 38 | 2 | CID000069726 | |
| Drug | 1,3-dimethylpurine-2,6,8-trione | 1.77e-04 | 12 | 38 | 2 | CID014754220 | |
| Drug | AC1NRACZ | 1.77e-04 | 12 | 38 | 2 | CID005287816 | |
| Drug | ((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one) | 1.77e-04 | 12 | 38 | 2 | ctd:C578491 | |
| Drug | AC1NRA5C | 1.99e-04 | 174 | 38 | 4 | CID005287709 | |
| Drug | Parthenolide [20554-84-1]; Down 200; 16.2uM; HL60; HG-U133A | 2.17e-04 | 178 | 38 | 4 | 1736_DN | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 2.31e-04 | 181 | 38 | 4 | 5963_DN | |
| Drug | cyclosporin analogs | 2.44e-04 | 14 | 38 | 2 | CID006475371 | |
| Disease | response to acetylsalicylate | 1.27e-04 | 16 | 31 | 2 | GO_1903492 | |
| Disease | stromal cell-derived factor 1 alpha measurement | 9.39e-04 | 43 | 31 | 2 | EFO_0008293 | |
| Disease | Arsenic Induced Polyneuropathy | 1.94e-03 | 62 | 31 | 2 | C0751852 | |
| Disease | Arsenic Encephalopathy | 1.94e-03 | 62 | 31 | 2 | C0751851 | |
| Disease | Arsenic Poisoning | 1.94e-03 | 62 | 31 | 2 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 1.94e-03 | 62 | 31 | 2 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 1.94e-03 | 62 | 31 | 2 | C0274862 | |
| Disease | psychotic symptoms | 2.75e-03 | 74 | 31 | 2 | EFO_0005940 | |
| Disease | electroencephalogram measurement | 2.75e-03 | 74 | 31 | 2 | EFO_0004357 | |
| Disease | Dermatologic disorders | 2.83e-03 | 75 | 31 | 2 | C0037274 | |
| Disease | susceptibility to strep throat measurement | 2.90e-03 | 76 | 31 | 2 | EFO_0008408 | |
| Disease | age at menopause | 3.86e-03 | 302 | 31 | 3 | EFO_0004704 | |
| Disease | Adenoid Cystic Carcinoma | 4.96e-03 | 100 | 31 | 2 | C0010606 | |
| Disease | response to vaccine, cytokine measurement | 8.36e-03 | 131 | 31 | 2 | EFO_0004645, EFO_0004873 | |
| Disease | viral load | 8.98e-03 | 136 | 31 | 2 | EFO_0010125 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSYREHYRSRKHKRR | 16 | P49760 | |
| RREDSYHVRSRSSYD | 46 | P49760 | |
| DRSSDRRVYDRRYCG | 61 | P49760 | |
| GHSRSRRAYLAYRER | 1216 | Q8IWK6 | |
| RRSYSREHEGRLRYP | 171 | P49761 | |
| RSRSHDRLPYQRRYR | 196 | P49761 | |
| QRRYRERRDSDTYRC | 206 | P49761 | |
| YYGPSRSRHRRRSRE | 231 | P49761 | |
| HYNNRRSRSGTYSSR | 411 | Q9UK58 | |
| YRNHRSSRETRDYAP | 256 | P0DJD3 | |
| DESYSRGYRNRRSSR | 286 | P0DJD3 | |
| RGYRNRRSSRETREY | 291 | P0DJD3 | |
| YRNHRSSRETRDYAP | 256 | A6NDE4 | |
| DESYSRGYRNRRSSR | 286 | A6NDE4 | |
| RGYRNRRSSRETREY | 291 | A6NDE4 | |
| YRNHRSSRETRDYAP | 256 | P0DJD4 | |
| DESYSRGYRNRRSSR | 286 | P0DJD4 | |
| RGYRNRRSSRETREY | 291 | P0DJD4 | |
| YRNHRSSRETRDYAP | 256 | P0C7P1 | |
| DESYSRGYRNRRSSR | 286 | P0C7P1 | |
| RGYRNRRSSRETREY | 291 | P0C7P1 | |
| YRNHRSSRETRDYAP | 256 | A6NEQ0 | |
| DESYSRGYRNRRSSR | 286 | A6NEQ0 | |
| RGYRNRRSSRETREY | 291 | A6NEQ0 | |
| YRNHRSSRETRDYAP | 256 | Q15415 | |
| RGYRNHRSSRETREY | 291 | Q15415 | |
| RDRYNRRRGRSRSYS | 166 | Q5T8P6 | |
| RSRSRSRERDGHYSN | 441 | Q8WUA2 | |
| YRYQRRSRSSSRSTE | 231 | Q9Y698 | |
| FAYYRRTHTANERRR | 2421 | Q8IWI9 | |
| RYREYAERGYERHRA | 506 | Q6UN15 | |
| SRNYRSRSRSHGYHR | 741 | Q7Z6E9 | |
| DRDRSRSKEYHRYRE | 581 | Q13427 | |
| YSRRGIRYRTIDEHD | 191 | Q8N131 | |
| SRSRDRHDDYYRERS | 511 | Q16630 | |
| RHDDYYRERSRERER | 516 | Q16630 | |
| DSRLRHYLGSRYDAR | 191 | Q8N9W5 | |
| KSHYYRDQRRERSRS | 486 | Q96S94 | |
| ERSRSYERTGRRYER | 496 | Q96S94 | |
| RSANGYYLSQRRHRA | 311 | Q9NQT6 | |
| ASRYHRRRSSGSRDE | 71 | Q9Y2E4 | |
| TDDTYYYRRRHRHER | 196 | Q9H819 | |
| IRRYSSEKHYGRESR | 371 | Q9UNA4 | |
| RSDRRRRYSSYRSHD | 1511 | Q5VV67 | |
| YRAEQSRTRRHLAEY | 321 | O43776 | |
| HYVRRTRQVTRYRNG | 171 | Q8IW70 | |
| RSQRSDSYHRGRSYN | 1416 | P30414 | |
| DSYHRGRSYNRRSRS | 1421 | P30414 | |
| RHGDFQRYRGYCSRR | 76 | Q9UHB9 | |
| RGRSIDQDYERAYHR | 241 | Q9UDY2 | |
| HYSARVRDPRTYDRR | 1276 | O15027 | |
| SYTPEYRRRRSRSHS | 86 | Q13595 | |
| SGSRDFSRHEQRYRL | 691 | Q96N46 | |
| DRRYHRSSPYRERTR | 431 | Q9BYW2 | |
| RERTRYSRPYTDNRA | 441 | Q9BYW2 | |
| RYERFERYRSGRSVQ | 301 | Q6ZVM7 | |
| RTTGDTERRYHLRYY | 111 | Q9C0B0 | |
| TGRRYGRRHAYVSFR | 21 | Q8NG27 | |
| RSHRRSRSRSYSRDY | 76 | P62995 | |
| SRSRSYSRDYRRRHS | 81 | P62995 |